{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T06:25:31Z","timestamp":1743402331323},"reference-count":29,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2024.14649","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T12:20:50Z","timestamp":1724934050000},"source":"Crossref","is-referenced-by-count":1,"title":["Coexistence of acute severe leukocytosis and anaplastic lymphoma kinase\u2011positive histiocytic sarcoma, a rare entity with an unusual presentation: A case report"],"prefix":"10.3892","volume":"28","author":[{"given":"Ertugrul","family":"Bayram","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Cukurova University Faculty of Medicine, Adana 01330, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umur","family":"Pehli\u0307van","sequence":"additional","affiliation":[{"name":"Department of Radiology, Baskent University Adana Dr. Turgut Noyan Application and Research Center, Adana 01240, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki\u0307vi\u0307lci\u0307m","family":"Erdogan","sequence":"additional","affiliation":[{"name":"Department of Pathology, Cukurova University Faculty of Medicine, Adana 01330, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Turker","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Adana City Training and Research Hospital, Adana 01330, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hafi\u0307ze","family":"Yalni\u0307z","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Cukurova University Faculty of Medicine, Adana 01330, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Semra","family":"Payda\u015f","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Cukurova University Faculty of Medicine, Adana 01330, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2024,8,29]]},"reference":[{"key":"key20241003102726_b1-ol-28-5-14649","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/ejh.12755","article-title":"Histiocytic sarcoma as a secondary malignancy: Pathobiology, diagnosis, and treatment","volume":"97","author":"Ansari","year":"2016","journal-title":"Eur J Haematol"},{"key":"key20241003102726_b2-ol-28-5-14649","doi-asserted-by":"publisher","first-page":"650","DOI":"10.5858\/arpa.2018-0349-RS","article-title":"Histiocytic sarcoma","volume":"144","author":"Hung","year":"2020","journal-title":"Arch Pathol Lab Med"},{"key":"key20241003102726_b3-ol-28-5-14649","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s41379-020-00673-x","article-title":"The mutational landscape of histiocytic sarcoma associated with lymphoid malignancy","volume":"34","author":"Egan","year":"2021","journal-title":"Mod Pathol"},{"key":"key20241003102726_b4-ol-28-5-14649","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1056\/NEJMoa1007056","article-title":"Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor","volume":"363","author":"Butrynski","year":"2010","journal-title":"N Engl J Med"},{"key":"key20241003102726_b5-ol-28-5-14649","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/ajh.25043","article-title":"Long-term effects of crizotinib in ALK-positive tumors (excluding NSCLC): A phase 1b open-label study","volume":"93","author":"Gambacorti-Passerini","year":"2018","journal-title":"Am J Hematol"},{"article-title":"Soft tissue and bone tumours","year":"2020","author":"International Agency for Research on Cancer (IARC)","key":"key20241003102726_b6-ol-28-5-14649"},{"key":"key20241003102726_b7-ol-28-5-14649","doi-asserted-by":"publisher","first-page":"509","DOI":"10.4103\/0377-4929.168866","article-title":"Anaplastic lymphoma kinase-positive pulmonary inflammatory myofibroblastic tumor with sarcomatous morphology and distant metastases: An unusual histomorphology and behavior","volume":"58","author":"Sethi","year":"2015","journal-title":"Indian J Pathol Microbiol"},{"key":"key20241003102726_b8-ol-28-5-14649","first-page":"13","article-title":"Safety and efficacy of anaplastic lymphoma kinase tyrosine kinase inhibitors in non-small cell lung cancer (Review)","volume":"45","author":"Wang","year":"2021","journal-title":"Oncol Rep"},{"key":"key20241003102726_b9-ol-28-5-14649","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12916-021-02207-x","article-title":"Intracranial efficacy of alectinib in ALK-positive NSCLC patients with CNS metastases-a multicenter retrospective study","volume":"20","author":"Zou","year":"2022","journal-title":"BMC Med"},{"key":"key20241003102726_b10-ol-28-5-14649","first-page":"104","article-title":"Classification of tumours editorial board. Soft tissue and bone tumours. Lyon (France): International agency for research on cancer","volume":"3","author":"WHO","year":"2020","journal-title":"Journal"},{"key":"key20241003102726_b11-ol-28-5-14649","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.6004\/jnccn.2021.0053","article-title":"Histiocytic neoplasms, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Go","year":"2021","journal-title":"J Natl Compr Cancer Netw"},{"article-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","year":"2008","author":"Swerdlow","key":"key20241003102726_b12-ol-28-5-14649"},{"key":"key20241003102726_b13-ol-28-5-14649","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-319-59632-7_1","article-title":"Pathology of histiocytic disorders and neoplasms and related disorders","volume-title":"Histiocytic disorders","author":"Picarsic","year":"2018"},{"key":"key20241003102726_b14-ol-28-5-14649","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.mayocp.2017.05.010","article-title":"Leukemic transformation in myeloproliferative neoplasms: A literature review on risk, characteristics, and outcome","volume":"92","author":"Yogarajah","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"key20241003102726_b15-ol-28-5-14649","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1182\/blood.2021013338","article-title":"ALK-positive histiocytosis: A new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition","volume":"139","author":"Kemps","year":"2022","journal-title":"Blood"},{"key":"key20241003102726_b16-ol-28-5-14649","first-page":"e7770","article-title":"Rare presentation of a rare tumor: Histiocytic sarcoma","volume":"12","author":"Reddivari","year":"2020","journal-title":"Cureus"},{"key":"key20241003102726_b17-ol-28-5-14649","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1056\/NEJMoa1408440","article-title":"First-line crizotinib versus chemotherapy in ALK-positive lung cancer","volume":"371","author":"Solomon","year":"2014","journal-title":"N Engl J Med"},{"key":"key20241003102726_b18-ol-28-5-14649","first-page":"2370","article-title":"ALK-G1269A mutation in epithelioid inflammatory myofibroblastic sarcoma after progression on crizotinib: A case report","volume":"17","author":"Xu","year":"2019","journal-title":"Oncol Lett"},{"key":"key20241003102726_b19-ol-28-5-14649","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/PAP.0000000000000228","article-title":"Epithelioid vascular tumors: A review","volume":"26","author":"Shon","year":"2019","journal-title":"Adv Anat Pathol"},{"key":"key20241003102726_b20-ol-28-5-14649","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.mpdhp.2018.06.002","article-title":"Update on cutaneous epithelioid vascular tumours","volume":"24","author":"Luzar","year":"2018","journal-title":"Diagnostic Histopathology"},{"key":"key20241003102726_b21-ol-28-5-14649","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.humpath.2024.01.014","article-title":"Vascular tumors of intermediate malignancy: An update","volume":"147","author":"Folpe","year":"2024","journal-title":"Hum Pathol"},{"key":"key20241003102726_b22-ol-28-5-14649","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1159\/000497210","article-title":"Myeloid sarcoma","volume":"42","author":"Magdy","year":"2019","journal-title":"Oncol Res Treat"},{"key":"key20241003102726_b23-ol-28-5-14649","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1309\/C38D-D8J3-JU3E-V6EE","article-title":"The immunophenotype of 325 adult acute leukemias: Relationship to morphologic and molecular classification and proposal for a minimal screening program highly predictive for lineage discrimination","volume":"117","author":"Thalhammer-Scherrer","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"key20241003102726_b24-ol-28-5-14649","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.anndiagpath.2018.03.008","article-title":"Interdigitating dendritic cell sarcoma: Clinicopathologic study of 8 cases with review of the literature","volume":"34","author":"Xue","year":"2018","journal-title":"Ann Diagn Pathol"},{"key":"key20241003102726_b25-ol-28-5-14649","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ejca.2020.06.037","article-title":"SOX10 is as specific as S100 protein in detecting metastases of melanoma in lymph nodes and is recommended for sentinel lymph node assessment","volume":"137","author":"Szumera-Cie\u0107kiewicz","year":"2020","journal-title":"Eur J Cancer"},{"key":"key20241003102726_b26-ol-28-5-14649","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/978-3-031-45024-2_16","article-title":"Markers and immunoprofile of lymphoid neoplasms","volume-title":"Immunohistochemistry in tumor diagnostics","author":"Tuffaha","year":"2023"},{"key":"key20241003102726_b27-ol-28-5-14649","doi-asserted-by":"publisher","first-page":"316","DOI":"10.32074\/1591-951X-331","article-title":"Follicular dendritic cell sarcoma","volume":"113","author":"Facchetti","year":"2021","journal-title":"Pathologica"},{"key":"key20241003102726_b28-ol-28-5-14649","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1080\/14737140.2016.1182427","article-title":"Central nervous system involvement in ALK-rearranged NSCLC: promising strategies to overcome crizotinib resistance","volume":"16","author":"Russo","year":"2016","journal-title":"Expert Rev Anticancer Ther"},{"key":"key20241003102726_b29-ol-28-5-14649","doi-asserted-by":"publisher","first-page":"379","DOI":"10.21037\/tlcr-22-638","article-title":"Targeting lung cancer brain metastases: A narrative review of emerging insights for anaplastic lymphoma kinase (ALK)-positive disease","volume":"12","author":"Nelson","year":"2023","journal-title":"Transl Lung Cancer Res"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T07:27:37Z","timestamp":1727940457000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2024.14649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,29]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,8,29]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2024.14649","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"type":"print","value":"1792-1074"},{"type":"electronic","value":"1792-1082"}],"subject":[],"published":{"date-parts":[[2024,8,29]]},"article-number":"516"}}